Skip to content
Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

17th Annual World Preclinical Congress – Boston, MA (18th-21st June)

Dr Colin Brown will be attending the 17th Annual World Preclinical Congress between 18th and 21st June in Boston.

World Preclinical Congress

Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech.

The World Preclinical Congress is a key networking event focusing on the latest trends and technologies impacting drug discovery and translational research.

Dr Brown will be meeting with partners with research interests in renal, hepatic and GI drug transporters. If you are attending the World Preclinical Congress and would like to arrange a meeting with Dr Brown, then please let us know – Contact Us

Don't miss out on our latest innovations: follow us on Linkedin

Author

Newcells Biotech

Published

15th June, 2018

Categories

Company News

Update

Get our latest updates straight to your inbox

Book a Call